For demonstration purposes only. Not a real fund or financial product.
NeuroWave

Owerview

Legal Name
NeuroWave Inc.
Location
Tokyo, Japan
Employees
50-200
IPO Status
Private
Last Funding TYPE
Series C
CB Rank
1063
Founded Date
2020

Description

NeuroWave is revolutionizing the neuroscience AI industry with advanced brainwave analytics designed to enhance cognitive health and mental well-being. By leveraging artificial intelligence, machine learning, and real-time neural data processing, the company develops innovative solutions that monitor brain activity, detect cognitive patterns, and provide insights into neurological conditions. Their technology supports researchers, healthcare professionals, and individuals seeking to optimize brain function, improve focus, and detect early signs of cognitive decline.

With a strong emphasis on precision and accessibility, NeuroWave’s AI-driven platforms integrate with EEG devices, neurofeedback systems, and wearable brain-monitoring technology. Their solutions enable early diagnosis of neurological disorders, personalized cognitive training, and real-time mental health assessments. Through collaborations with medical institutions, neuroscience researchers, and wellness technology providers, NeuroWave is shaping the future of cognitive health—where AI-powered brainwave analytics unlock new possibilities for mental performance, early intervention, and long-term neurological well-being.